Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gilles Sauvé

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Organic Letters|July 6, 2002
Silver(I) oxide mediated highly selective monotosylation of symmetrical diols. Application to the synthesis of polysubstituted cyclic ethersAbderrahim Bouzide, Gilles Sauvé
Expert Opinion on Therapeutic Targets|January 24, 2003
Targeting HIV-1 integraseKhampoune Sayasith, Gilles Sauvé, Jocelyn Yelle
Bioorganic & Medicinal Chemistry Letters|February 17, 2005
Lysine derivatives as potent HIV protease inhibitors. Discovery, synthesis and structure-activity relationship studiesAbderrahim Bouzide, Gilles Sauvé, Jocelyn Yelle
Bioorganic & Medicinal Chemistry Letters|September 25, 2003
1,2,5,6-tetra-O-benzyl-D-mannitol derivatives as novel HIV protease inhibitorsAbderrahim Bouzide, Gilles Sauvé, Guy Sévigny, et al.
Bioorganic & Medicinal Chemistry Letters|December 4, 2003
Lysine sulfonamides as novel HIV-protease inhibitors: optimization of the Nepsilon-acyl-phenyl spacerBrent R Stranix, Gilles Sauvé, Abderrahim Bouzide, et al.
Bioorganic & Medicinal Chemistry Letters|July 1, 2004
Lysine sulfonamides as novel HIV-protease inhibitors: Nepsilon-disubstituted ureasBrent R Stranix, Gilles Sauvé, Abderrahim Bouzide, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Organic Letters|July 6, 2002
Silver(I) oxide mediated highly selective monotosylation of symmetrical diols. Application to the synthesis of polysubstituted cyclic ethersAbderrahim Bouzide, Gilles Sauvé
Expert Opinion on Therapeutic Targets|January 24, 2003
Targeting HIV-1 integraseKhampoune Sayasith, Gilles Sauvé, Jocelyn Yelle
Bioorganic & Medicinal Chemistry Letters|February 17, 2005
Lysine derivatives as potent HIV protease inhibitors. Discovery, synthesis and structure-activity relationship studiesAbderrahim Bouzide, Gilles Sauvé, Jocelyn Yelle
Bioorganic & Medicinal Chemistry Letters|September 25, 2003
1,2,5,6-tetra-O-benzyl-D-mannitol derivatives as novel HIV protease inhibitorsAbderrahim Bouzide, Gilles Sauvé, Guy Sévigny, et al.
Bioorganic & Medicinal Chemistry Letters|December 4, 2003
Lysine sulfonamides as novel HIV-protease inhibitors: optimization of the Nepsilon-acyl-phenyl spacerBrent R Stranix, Gilles Sauvé, Abderrahim Bouzide, et al.
Bioorganic & Medicinal Chemistry Letters|July 1, 2004
Lysine sulfonamides as novel HIV-protease inhibitors: Nepsilon-disubstituted ureasBrent R Stranix, Gilles Sauvé, Abderrahim Bouzide, et al.
Pageof 1